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Novel internally quenched fluorescence peptide substrates containing sequence specific sites for cleavage by multiple proteases
were designed and synthesized. The 28 and 29 residue peptides contain an N-terminal fluorescence acceptor group, 4-(4-dimeth-
ylaminophenylazo)benzoic acid (DABCYL), and a C-terminal fluorescence donor group, 5-(2-aminoethylamino)naphthalene-1-
sulfonic acid (EDANS). Efficient energy transfer between the donor and acceptor groups flanking the peptide sequence was achieved
by incorporation of a central DPro-Gly segment, which serves as a conformation nucleating site, inducing hairpin formation. This
multispecificity protease substrate was used to profile the proteolytic activities in the malarial parasite Plasmodium falciparum in a
stage dependent manner using a combination of fluorescence and MALDI mass spectrometry. Cysteine protease activity was shown
to be dominating at neutral pH, whereas aspartic protease activity contributed predominantly to the proteolytic repertoire at acidic
pH. Maximum proteolysis was observed at the trophozoite stage followed by the schizonts and the rings.
 2003 Elsevier Inc. All rights reserved.
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Mass spectrometrySelective expression of proteases and controlled pro-
teolytic activity is a hallmark of developmental pro-
cesses in biology [1]. Plasmodium falciparum, the
causative agent for the most lethal form of malaria,
displays a carefully orchestrated cascade of proteolytic
events throughout its life cycle, which is essential for its
survival and propagation [2,3]. Proteases belonging to
four major classes namely serine, aspartic, cysteine, and
metalloproteases have been reported from the parasite.
The entire proteolytic activity during the intraerythro-
cytic stage may be divided into two categories—prote-
olysis involved in hemoglobin degradation [4] and
proteolysis involved in erythrocyte rupture and mero-
zoite invasion of fresh erythrocytes [5]. Proteolytic ac-
tivity in the parasite depends on the developmental stage
and may also be localized in specialized organelles as in* Corresponding author. Fax: +91-80-360-0683.
E-mail address: pb@mbu.iisc.ernet.in (P. Balaram).
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doi:10.1016/j.bbrc.2003.08.108the case of hemoglobin degradation, which occurs in the
food vacuole at pH 5 [6,7]. Consequently, the vacuolar
proteases display optimal hemoglobinase activity
around this pH. Several hemoglobinases have been
identified and characterized, including four aspartic
proteases—plasmepsin I, II, IV, and histo-aspartic pro-
tease (HAP) [8–11], three cysteine proteases—falcipain 1,
2, and 3 [12–14], and at least one metalloprotease—fal-
cilysin [15]. The second pool of proteolysis, which is
related with erythrocyte rupture and invasion, involves
the cytosolic environment, where the pH is near neutral.
Thus, cellular proteolytic activity can also be modulated
by local environmental conditions.
We describe in this report a new approach to the
deconvolution of the repertoire of proteolytic activity in
the intraerthrocytic stage of P. falciparum in a class
specific manner at different stages of parasite growth.
The present study is based on the use of designed,
internally quenched fluorescent ‘universal’ protease
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Application of a combination of fluorescence and mass
spectral analysis permits the profiling of P. falciparum
proteolysis.Materials and methods
Synthesis of the peptide substrate. Internally quenched peptides were
synthesized following the method described by Luker et al. [8] with
modifications. The peptide 1 (Fig. 1) was assembled by Fmoc solid
phase chemistry on a flow synthesizer. Peptide 2 was obtained as a
deletion product, which was purified and characterized. All amino acids
were protected at the N-terminus with the Fmoc group (NovaBio-
chem). The side chains of Asp, Glu, and Ser were protected with t-Bu
group, Arg with Mtr group, Cys with trityl group, and Lys with Boc
group. The coupling reaction proceeded using the Opfp esters of the
protected amino acids on PAC-PEG-PS resin (Perspective Biosystems).
Fmoc deprotections were done with 20% piperidine in dimethylfor-
mamide. The resin assembled peptide was subsequently cleaved in 94%
TFA, containing 5% anisole and 1% ethanedithiol as cation scavengers.
The isolated crude peptide was dissolved in a 9:1 mixture of THF and
water. 5-(2-(iodoacetyl)aminoethyl)amino naphthalene-1-sulfonate
(IAEDANS) was added five times in excess to the solution at pH 8.0.
The purification of the peptide was achieved by reverse phase HPLC on
a C18 column with a linear gradient of acetonitrile containing 0.1%
TFA. The purified peptides were characterized by MALDI-TOF mass
spectrometry—peptide 1:Mcalc ¼ 3665,Mobs ¼ 3689 [M+Na]þ; peptide
2: Mcalc ¼ 3509, Mobs ¼ 3532 [M+Na]þ.
Parasite culture, isolation, and assay for protease activity. P. falci-
parum (strain T9/106) culture grown by the candle jar method [16] was
synchronized by treatment with sorbitol. Cells isolated by saponin
treatment at the ring, trophozoite, and schizont stages were suspended
in the buffer to be used for protease assay—100mM sodium phosphate
(pH 7.2) or 100mM sodium acetate (pH 4.8), containing 5mM DTT
and sonicated briefly over ice. The lysed suspension was clarified of
hemozoin pigments by centrifuging at 20,000g for 15min. The super-
natant was directly used for the protease assay avoiding storage.Fig. 1. Sequences of the universal protease substrates 1 anSpecific inhibitors used in the assay were 10 lM E64 (N-(trans-epox-
ysuccinyl)-L-leucine-4-guanidinobutylamide), 10lM PMSF (phenyl-
methylsulfonyl fluoride), 10lM pepstatin A, and 1mM EDTA
(ethylenediaminotetraacetic acid). Prior to the assay, the cell lysates
were incubated for 30min in the presence of the inhibitors. The assay
was done in 500ll of 100mM buffer (sodium phosphate, pH 7.2, or
sodium acetate, pH 4.8), with 5mM DTT and 1.8lM peptide sub-
strate. Proteolysis was monitored as increase in emission intensity with
time at 490 nm, following excitation at 335 nm. A Perkin–Elmer LS55B
fluorimeter was used with excitation and emission bandpass kept at 7
and 10 nm, respectively.
MALDI mass spectrometry. For recording MALDI spectra, the
reaction volume was brought down to 50ll and the reaction was
stopped by freezing in liquid nitrogen. MALDI spectra were recorded
in positive ion mode using a KOMPACT SEQ spectrometer (Kratos-
Shimadzu Analytical, Manchester, UK). The matrices used for positive
ion mode detection were a-cyano-4-hydroxycinnamic acid and 3,5-di-
methoxy-4-hydroxycinnamic acid in 60% acetonitrile containing 0.1%
TFA. Routinely, 0.5 ll of matrix was mixed with 0.5 ll of the reaction
solution on a MALDI plate for mass spectral analysis. Each sample
was spotted thrice and spectra were recorded for each spot. After
proteolysis, the N-terminal fragments were readily detectable. C-ter-
minal fragments ionized poorly under the conditions used, presumably
due to the dansyl sulfonic acid moiety, which forms tight ion pairs.Results and discussion
Fig. 1 shows the sequences of two substrates with
specific cleavage points indicated. Peptide 2 lacks a sec-
ond trypsin site, which is present in peptide 1 (–Met–
Arg–Glu–). The peptides incorporate a central DPro-Gly
segment, which facilitates hairpin formation [17,18], thus
permitting population of a range of conformations in
which the fluorescent donor and acceptor groups lie at
distances that facilitate quenching by fluorescence reso-
nance energy transfer (FRET) [19–21]. This strategyd 2. Potential protease cleavage sites are indicated.
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tease cleavage sites into a single substrate molecule. Thus
far, the use of internally quenched fluorescent substrates
has been limited to relatively short peptide sequences (8–
12 residues), since the efficiency of quenching diminishes
rapidly as the length of the intervening polypeptide in-
creases [19]. FRET based protease assays have been used
in the literature for monitoring many therapeutically and
physiologically important enzymes like the retroviral
proteases [22], renin [23], hepatitis A3C protease [24],
interleukin 1b converting enzyme (ICE) [25], Leishmania
surface metalloprotease [26], anthrax lethal factor [27],
Candida albicans aspartic protease [28], papain [29], and
the plasmodial protease—plasmepsin II [8,30,31]. The
chromophores chosen as fluorescence donor and accep-
tor are 5-(2-aminoethylamino)naphthalene-1-sulfonic
acid (EDANS) and 4-(4-dimethylaminophenylazo)ben-
zoic acid (DABCYL), respectively. The fluorescence
emission band of EDANS (490 nm) displays excellent
overlap with the broad visible absorption band of
DABCYL. The Forster distance ðR0Þ for these two
chromophores is estimated to be about 33A [22].
Plasmodium falciparum cells were isolated from
highly synchronized in vitro culture at three morpho-
logically distinct stages namely—ring, trophozoite, and
schizont. Protease activities in the lysates of these cells
were monitored at pH 7.2 and 4.8 using peptide 2
(Fig. 1). Measurement of proteolysis by members of any
one particular class was achieved by including a com-
bination of class-specific inhibitors in the reaction mix-Fig. 2. MALDI mass spectrum of peptide 2 treated with P. falciparum
trophozoite extract at pH 7.2 in the absence of any inhibitors (see
Materials and methods for details). All the peaks are marked by the
corresponding masses (Da). Mass of 3532 corresponds to the intact
peptide. Inset: Emission spectra of peptide 2 at pH 7.2 (broken line)
and after addition of P. falciparum trophozoite extract (solid line).
Excitation: 335 nm.ture. Inhibitors used were E64—cysteine protease;
PMSF—serine protease, pepstatin A—aspartic protease,
and EDTA—metalloprotease. Fig. 2 shows representa-
tive fluorescence and mass spectra obtained upon
cleavage of peptide 2 by a trophozoite extract. Fig. 3
summarizes the results of assays of protease activities
from different developmental stages of the parasite, ex-
pressed as an increase in fluorescence intensity of
EDANS. In each case, inclusion of all four inhibitors
resulted in no increase in fluorescence, while maximum
activity was obtained in the absence of any inhibitor.
This validated the use of such an assay system and
confirmed the ability of these four inhibitors, working inFig. 3. Protease activity in cell lysates of P. falciparum at pH 7.2 (left
panel) and 4.8 (right panel). Cell lysates at ring (A and D), trophozoite
(B and E), and schizont (C and F) stages were assayed using peptide 2
in the presence of E64, pepstatin A, PMSF, and EDTA (asterisk); E64,
PMSF, and EDTA (closed circle); pepstatin A, PMSF, and EDTA
(triangle); and E64, pepstatin A, and EDTA (open circle) or in the
absence of any inhibitor (square). Proteolysis is presented here as an
increase in fluorescence emission intensity with time at 490 nm fol-
lowing excitation at 335 nm.
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Differences in total protease activities between acidic
and neutral pH were minimum in the trophozoite stage
(Figs. 3B and E). There was significantly higher protease
activity at acidic pH compared to the neutral pH in the
schizont stage (Figs. 3C and F). The ring stage however
presented a stark difference in proteolytic activity at the
two pH values, having almost negligible total protease
activity at pH 7.2 (Figs. 3A and D). This observation
could be substantiated by taking into account the rela-
tive ratio of cytoplasm to food vacuole. In the ring stage
the parasite cell is dominated by the presence of the food
vacuole, which leaves only a thin smear of cytoplasm
around it. This stage also marks the cellular preparation
for large-scale hemoglobin degradation in the food
vacuole and hence, the upregulation of acidic protease
activity (Fig. 3D). Cytoplasmic proteases are largely
involved with rupture and invasion and both these
processes are inconspicuous in the ring stage. This may
be one of the reasons for the very low levels of neutral
protease activity in the ring stage (Fig. 3A). Also, min-
imum overall protease activity in the ring stage could be
a reflection of low cellular protein content. The tro-
phozoite stage is marked by extensive hemoglobin deg-
radation, combined with cellular growth. The
appearance of significant activity corresponding to
neutral proteases may be attributed to increased cyto-
plasmic content at this stage (Fig. 3B). This also indi-
cates the beginning of cellular processes that lead to
rupture of the RBC at the end of the intraerythrocytic
cycle. The schizont stage with distinct daughter cells is
decorated by the largest parasitoporous vacuole that
occupies most of the intracellular chamber inside RBC.
Complete disappearance of the food vacuole is seen in
this stage. Hence, comparable acidic protease activity
between the schizont and trophozoite stages was unex-Table 1
Sites cleaved by P. falciparum cell extract at the trophozoitea stage identified
Protease class pH Site of cleavage [Fra
Asparticb 7.2 F21-L22 [1–2
4.8 F21-L22 [1–2
Cysteinec 7.2 S23-F24 [1–2
L18-E19 [1–1
4.8 S23-F24 [1–2
L18-E19 [1–1
All proteasesd 7.2 F21-L22 [1–2
S23-F24 [1–2
L18-E19 [1–1
4.8 F21-L22 [1–2
S23-F24 [1–2
L18-E19 [1–1
aMasses observed for all the three stages (ring, trophozoite, and schizon
b In the presence of E64, PMSF, and EDTA.
c In the presence of pepstatin A, PMSF, and EDTA.
d In the absence of any inhibitor.
eAdduct of 16Da results because of oxidation of the fragments containipected. In all the three stages aspartic protease activity
contributed maximally towards total activity, with sig-
nificant contribution from the cysteine proteases at pH
4.8, whereas the scenario was reversed at neutral pH.
Recent reports emphasizing cysteine protease activity
involved in the process of rupture [32] and invasion [33]
validate the presence of high level of cysteine protease
activity at pH 7.2 in trophozoite and schizont stages
(Figs. 3B and C).
Two serine proteases resembling subtilisin—PfSub-
1[34] and PfSub-2 [35] have been cloned and character-
ized from P. falciparum in addition to evidences for the
presence of other serine protease activities. Our assay
did not detect serine and metalloprotease activities in
any significant amount. Two factors may account for
this observation: (i) though important from a cellular
point of view, these proteases may not be present in
abundance or (ii) the substrate used does not contain a
suitable site for cleavage by these proteases, although
model studies demonstrate ready cleavage by common
serine proteases like trypsin, chymotrypsin, and subtili-
sin, and also by metalloenzymes like carboxypeptidase
(data not shown). It should also be emphasized that
earlier studies suggested that serine protease activity is
detectable only after treatment with phospholipase,
which releases the protease from the membrane anchor
[36]. One possible reason for the absence of serine pro-
tease activity in our assay could be that the protease
remained attached to the membrane fragments and
hence, rendered inactive under our experimental condi-
tions.
Cleavage sites in the peptide under diverse conditions
were established by MALDI mass spectrometry of the
cleavage products. Mass spectra determined after incu-
bation with parasite lysate showed the presence of sa-
tellite peaks, which differed in mass of 38Da from theby MALDI mass spectrometry
gment], Expected mass (Mþ) Observed masse (MHþ)
1], 2449 2468
1], 2449 2468
3], 2649 2664
8], 2171 2170
3], 2649 2662
8], 2171 2169
1], 2450 2467
3], 2649 2667
8], 2171 2173
1], 2450 2467
3], 2649 2667
8], 2171 2173
t) were the same under any particular condition of assay.
ng Met to its sulfoxide.
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may be noted that during preparation of the parasite
lysates PBS was used, which has a potassium ion con-
centration of about 45mM. The parent peaks are as-
signed to the protonated species [MHþ]. Furthermore,
the fragments appear to be oxidized to the sulfoxide,
resulting in an adduct mass of 16Da. The peaks ob-
tained under a particular condition of assay were es-
sentially identical in all three stages of parasite growth.
Presence of all four inhibitors resulted in complete ab-
sence of any peak corresponding to substrate fragments.
Table 1 shows the sites of cleavage determined from
MALDI mass spectral analysis at the trophozoite stage.
Under all conditions the aspartic proteases were able to
cleave the substrate only at positions F21-L22. This site
corresponds to the reported plasmepsin II [37] cleavage
preference. Plasmepsin I and HAP were also reported to
possess the same cleavage preference. Cysteine proteases
cleaved the substrate at two sites L18-E19 and S23-F24
under all conditions. All the three cleavage sites were
detected when the assay was done in the absence of any
inhibitor.
Sequencing of the malarial genome reveals the pres-
ence of about 29 genes annotated as proteases [38]. Ten
genes coding for aspartic proteases have been identified
[39] of which seven were shown to be expressed in the
intraerythrocytic stages [11]. Similarly, there are several
genes in the P. falciparum genome putatively coding for
cysteine proteases other than the well-characterized
falcipains. This raises questions on the existence of more
than one enzyme with seemingly similar substrate
specificity that performs the same cellular function such
as hemoglobin degradation. Most proteases display
sharp dependence on pH for proteolysis. In our assay,
both cysteine and aspartic protease activities are ob-
served at both acidic and neutral pH. Though surpris-
ing, this observation is consistent with the reports
showing neutral pH activity for both plasmepsin II [40]
and falcipain 2 [41]. Our data also suggest that there is
no alteration in substrate recognition by both classes of
proteases between acidic and neutral pH. Whether each
member of a class of proteases is programmed to be
localized in either the food vacuole or in the cytoplasm,
or the same protease functions in both compartments
needs to be answered.
In summary, we have presented here a novel FRET
based protease substrate designed to harbor cleavage
sites preferred by multiple proteases. Limitations in the
length of the peptide from the point of view of efficient
internal quenching have been overcome by inducing the
peptide to fold into a b-hairpin using a centrally posi-
tioned conformation nucleating site. This substrate has
been used to profile the protease activities in a complex
mixture like a P. falciparum cell extract. Proteases are
central to the survival of many disease-causing parasites,
which make them attractive targets for therapeutic in-tervention [1]. Identification of these proteases and their
characterization is often hampered by the lack of in-
formation regarding their catalytic preferences and
limited availability from the natural source. Our ap-
proach of using a universal substrate not only presents a
highly sensitive way of monitoring multiple proteases of
varied specificities, but also provides information re-
garding the nature of the cleavage sequence preferred by
individual enzymes. It is clear that this approach also
lends itself to large-scale screening of proteases using a
combination of automated fluorescence and mass spec-
trometric methods.Acknowledgments
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